David A. Siegel Akero Therapeutics, Inc. Put Options Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
168Shares Held
72.7MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$185 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$151 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$146 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$141 Million3.88% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$138 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.25B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...